Optimize drug therapy and monitor patient adherence.
Quantitative Liquid Chromatography-Tandem Mass Spectrometry
Timing of specimen collection: Pre-dose (trough) draw - At steady state concentration.
Plain red. Also acceptable: Lavender (K2 or K3EDTA) or pink (K2EDTA).
Separate serum or plasma from cells within 2 hours of collection. Transfer 2 mL serum or plasma to an ARUP Standard Transport Tube. (Min: 1 mL)
Whole blood. Light blue (citrate) or yellow (SPS or ACD solution).
After separation from cells: Ambient: 12 hours; Refrigerated: 72 hours; Frozen: 5 days
Effective February 19, 2013
|Child (0 - 11 years)
||Adult (12 years and older)
|Therapeutic Range||30-80 ng/mL||50-300 ng/mL|
|Toxic Level||Greater than 200 ng/mL||Greater than 750 ng/mL|
Toxic concentrations may cause drowsiness, coma, hypotension, tachycardia and seizures. Large daily doses of chlorpromazine may cause phenothiazine sudden death syndrome.
Compliance Statement B: For laboratory developed tests not using a RUO kit, and for FDA approved, cleared or 510(k) exempt assays with alterations. This test was developed and its performance characteristics determined by ARUP Laboratories. The U. S. Food and Drug Administration has not approved or cleared this test; however, FDA clearance or approval is not currently required for clinical use. The results are not intended to be used as the sole means for clinical diagnosis or patient management decisions.
80342 (Alt code: G0480)
|Component Test Code*||Component Chart Name||LOINC|
- Thorazine Spansule